Autophagy-activating foods like pomegranates help prevent gut diseases

dd453097-a20a-43dd-a2aa-e295cd77e080articleimage.jpg

03 Nov 2017 --- Colon cancer, Crohn’s and other diseases of the gut could be better treated – or even prevented – thanks to a new link between inflammation and a common cellular process that has been established by the UK’s University of Warwick. Led by Dr. Ioannis Nezis at Warwick’s School of Life Sciences, new research demonstrates that autophagy – an essential process whereby cells break down and recycle harmful or damaged elements within themselves to keep our bodies healthy – causes tissue inflammation when dysfunctional, which in turn leaves us susceptible to harmful diseases, particularly in the gut.

“Understanding the molecular mechanisms of selective autophagy and inflammation will help to use interventions to activate the autophagic pathway to prevent inflammation and promote healthy wellbeing during the life course,” says Dr. Ioannis Nezis, the lead author of the research.

“Natural compounds contained in fruits and vegetables like pomegranates, red grapes, pears, mushrooms, lentils, soybeans and green peas have been shown to activate autophagy, therefore inclusion of the above in our diet would help to prevent inflammation and alleviate the symptoms of gut diseases,” Nezis adds.

Understanding this link could lead to more effective treatments for gut diseases – such as colon cancer, irritable bowel syndrome, Crohn’s disease and ulcerative colitis – giving healthcare professionals the ability to target the root cause of these diseases, by regulating and controlling autophagy.

Protein called Kenny is key
In the new paper published in Nature Communications, Dr. Nezis and colleagues identify – for the first time – a protein which is regulated by autophagy. Called Kenny, the protein contains a motif of amino acids that causes itself to be broken down by autophagy. When autophagy is dysfunctional, Kenny accumulates and causes inflammation.

The researchers identified this phenomenon in fruit flies, by turning Kenny fluorescent – so it would be visible – and observing at a microscopic level that the protein was present in the cell where autophagy was occurring.

They also noted that dysfunctional autophagy causes serious inflammation in fruit flies – particularly in the gut – which makes tissue inflamed, causing disease, and making the lifespan of a fruit fly half that of other flies.

To prevent serious diseases of the gut caused by inflammation, Dr. Nezis and his colleagues state that it is necessary to find ways to control and regulate autophagy.

Humans are in even more danger from the link between autophagy, inflammation and a dysfunctional or diseased gut. This is because our bodies lack the regular motif of amino acids which Kenny uses in fruit flies, making its breakdown by autophagy difficult to control or regulate.

The paper, “Kenny mediates selective autophagic degradation of the IKK complex to control innate immune responses,” will be published in Nature Communications.

Other recent news in anti-inflammation research includes a report suggesting that omega 3 fatty acid, probiotic, prebiotic, antioxidant and polyphenol interventions are useful as a means to influence “inflammaging” – aging characterized by increased levels of inflammatory markers in the bloodstream. Meanwhile, researchers have found evidence of the inhibitory effect in colon tumorigenesis of a low-dose combination of aspirin and Sabinsa’s Curcumin C3 Complex, suggesting an inhibiting effect on colorectal cancer.

RELATED ARTICLES
Homepicture

Fermentalg reports on Q1 revenue as US expansion begins

20 Apr 2018 Fermentalg, a French supplier of microalgae for ...

Homepicture

CJ CheilJedang to expand L-Arginine and L-Citrulline production in Indonesia

13 Apr 2018 8 --- CJ CheilJedang is making plans to build a ...

Homepicture

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 Novartis has entered into an agreement and plan ...

Homepicture

GSK to take full ownership of Novartis stake in Consumer Healthcare Business for US$13bn

27 Mar 2018 GlaxoSmithKline (GSK) has reached an agreement ...

Homepicture

Probi signs agreement with pharma company Cilag on probiotic OTC product

23 Mar 2018 Probi has signed a long-term agreement with ...